Belgia - inglise - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva b.v. - tiagabine hydrochloride 17,2 mg - eq. tiagabine 15 mg - film-coated tablet - 15 mg - tiagabine hydrochloride 17.2 mg - tiagabine

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

stat rx usa llc - tiagabine hydrochloride (unii: dqh6t6d8oy) (tiagabine - unii:z80i64hmnp) - tiagabine 12 mg - gabitril (tiagabine hydrochloride) is indicated as adjunctive therapy in adults and children 12 years and older in the treatment of partial seizures. gabitril is contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients. the abuse and dependence potential of gabitril have not been evaluated in human studies.

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

orphan australia pty ltd - tiagabine hydrochloride monohydrate -

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

lake erie medical & surgial supply dba quality care products llc - tiagabine hydrochloride (unii: dqh6t6d8oy) (tiagabine - unii:z80i64hmnp) - tiagabine hydrochloride 4 mg

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

virtus pharmaceuticals llc - levomefolate calcium (unii: a9r10k3f2f) (levomefolic acid - unii:8s95dh25xc), pyridoxal phosphate anhydrous (unii: f06sge49m6) (pyridoxal phosphate anhydrous - unii:f06sge49m6), methylcobalamin (unii: br1sn1js2w) (methylcobalamin - unii:br1sn1js2w) - levomefolate calcium 3 mg - there have been rare reports of hypersensitivity (allergic-like reactions) to l-methyl-b6-b12 tablets . therefore, a known hypersensitivity to any of the components in the product is a contraindication to its use for any indication.

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

virtus pharmaceuticals llc - levomefolate calcium (unii: a9r10k3f2f) (levomefolic acid - unii:8s95dh25xc), methylcobalamin (unii: br1sn1js2w) (methylcobalamin - unii:br1sn1js2w), acetylcysteine (unii: wyq7n0bpyc) (acetylcysteine - unii:wyq7n0bpyc) - levomefolate calcium 6 mg - l-methyl-mc-nac tablets is indicated for the distinct nutritional requirements of individuals under a physician's treatment for early memory loss 25 with particular emphasis for those individuals diagnosed with or at risk for neurovascular oxidative stress 14,16,18 and/or hyperhomocysteinemia 18 ; mild to moderate cognitive impairment with or without vitamin b12 deficiency 9,13,19 , vascular dementia 12,13,21 or alzheimer's disease 12,13,16,21 . l-methyl-mc-nac tablets should always be used under medical supervision. there have been rare reports of hypersensitivity (allergic-like reactions) to l-methyl-mc-nac tablets. therefore, a known hypersensitivity to any components in the product is a contraindication to its use for any indication.

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

avkare, inc. - levomefolate calcium (unii: a9r10k3f2f) (levomefolic acid - unii:8s95dh25xc), methylcobalamin (unii: br1sn1js2w) (methylcobalamin - unii:br1sn1js2w), acetylcysteine (unii: wyq7n0bpyc) (acetylcysteine - unii:wyq7n0bpyc) - levomefolate calcium 6 mg - l-methyl-mc-nac tablets is indicated for the distinct nutritional requirements of individuals under a physician's treatment for early memory loss 25 with particular emphasis for those individuals diagnosed with or at risk for neurovascular oxidative stress 14,16,18 and/or hyperhomocysteinemia 18 ; mild to moderate cognitive impairment with or without vitamin b12 deficiency 9,13,19 , vascular dementia 12,13,21 or alzheimer's disease 12,13,16,21 . l-methyl-mc-nac tablets should always be used under medical supervision. there have been rare reports of hypersensitivity (allergic-like reactions) to l-methyl-mc-nac tablets. therefore, a known hypersensitivity to any components in the product is a contraindication to its use for any indication.